Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.92% |
| Sep 30, 2025 | 77.90% |
| Jun 30, 2025 | -0.30% |
| Mar 31, 2025 | -834.72% |
| Dec 31, 2024 | 92.20% |
| Sep 30, 2024 | -564.81% |
| Jun 30, 2024 | 79.18% |
| Mar 31, 2024 | -450.78% |
| Dec 31, 2023 | -121.34% |
| Sep 30, 2023 | 68.46% |
| Jun 30, 2023 | -869.22% |
| Mar 31, 2023 | 94.78% |
| Dec 31, 2022 | 10.62% |
| Sep 30, 2022 | -28.55% |
| Jun 30, 2022 | -22.56% |
| Mar 31, 2022 | -66.82% |
| Dec 31, 2021 | 76.42% |
| Sep 30, 2021 | -43.96% |
| Jun 30, 2021 | 40.14% |
| Mar 31, 2021 | -7,706.34% |